GAREN G. BOHLIN

Insider Reports History

Location
Waltham, MA
Signature
/s/ Nancy Smith, Attorney-in-Fact for Garen Bohlin
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by GAREN G. BOHLIN:

Company Role Class Num Shares Value Price $ Report Date Ownership
COLLEGIUM PHARMACEUTICAL, INC Director Common Stock 62,259 $1,667,296 $26.78 15 May 2025 Direct
Karyopharm Therapeutics Inc. Director Nonstatutory Stock Option (right to buy) 4,600 28 May 2025 Direct

Insider Reports Filed by GAREN G. BOHLIN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KPTI Karyopharm Therapeutics Inc. 28 May 2025 1 $0 4 Director 29 May 2025, 16:05
COLL COLLEGIUM PHARMACEUTICAL, INC 15 May 2025 1 $0 4 Director 19 May 2025, 17:42
KPTI Karyopharm Therapeutics Inc. 29 May 2024 1 $0 4 Director 30 May 2024, 17:19
COLL COLLEGIUM PHARMACEUTICAL, INC 14 May 2024 4 -$770,227 4 Director 16 May 2024, 19:20
KPTI Karyopharm Therapeutics Inc. 12 Sep 2023 1 +$49,985 4 Director 12 Sep 2023, 16:07
KPTI Karyopharm Therapeutics Inc. 24 May 2023 1 $0 4 Director 25 May 2023, 16:05
COLL COLLEGIUM PHARMACEUTICAL, INC 18 May 2023 1 $0 4 Director 19 May 2023, 16:37
COLL COLLEGIUM PHARMACEUTICAL, INC 19 May 2022 1 $0 4 Director 23 May 2022, 16:43
KPTI Karyopharm Therapeutics Inc. 19 May 2022 1 $0 4 Director 20 May 2022, 16:03
KPTI Karyopharm Therapeutics Inc. 21 May 2021 1 $0 4 Director 21 May 2021, 17:31
COLL COLLEGIUM PHARMACEUTICAL, INC 20 May 2021 1 $0 4 Director 24 May 2021, 17:14
KPTI Karyopharm Therapeutics Inc. 06 May 2021 1 +$31,280 4 Director 10 May 2021, 19:57